Welcome!
BioNTech SE
Covid-19
BioNTech and Fosun Pharma to supply China with mRNA-based Covid-19 vaccine
The initial supply of 100 million doses will be delivered from BioNTech’s production facilities in Germany.
December 16, 2020
Covid-19
BioNTech gets downgrade from analyst amid vaccine competition
A BioNTech SE analyst advised investors to cash in on their profits from the US$30 billion biotech’s recent advance.
December 01, 2020
Covid-19
Some Asian investors may have exited vaccine stock prematurely
This may be a trade to regret.
November 13, 2020